Operating Expenses
$853.22M
TTM · Period ending: · USD

RPRX Operating Expenses
What is operating expenses?
Expenses from normal business operations (SG&A, R&D, etc.).
RPRX operating expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Expenses (USD) |
|---|---|
| 818,675,000 | |
| 971,132,000 | |
| 862,404,000 | |
| 1,930,150,000 | |
| 858,748,000 | |
| 526,954,000 | |
| -808,922,000 | |
| 430,448,000 | |
| 658,238,000 | |
| 1,086,333,000 | |
| 789,982,000 |
Frequently asked questions: RPRX operating expenses
What is Royalty Pharma plc (RPRX)'s current operating expenses?
Royalty Pharma plc (RPRX)'s latest reported operating expenses (TTM) is $853.22M as of Sep 30, 2026. Expenses from normal business operations (SG&A, R&D, etc.).
How much historical operating expenses data is available for RPRX?
Stock Alarm Pro provides 11 dated annual fiscal periods observations for Royalty Pharma plc (RPRX)'s operating expenses, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare RPRX's operating expenses to peers or set an alert?
You can open RPRX's operating expenses in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on RPRX delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance